New chairperson at company focused on microbiome science in animal health
ANIZOME LLC, a company focused on the commercial application of microbiome science in animal health by leveraging insights from the role of the microbiome in human healthcare, has announced the appointment of Dr Bénédicte Flambard as the chairperson of its Board of Directors.
Dr Flambard specializes in heading the innovation and development of commercial strategies within the animal and human healthcare sectors. She is currently global head of plant health business at chemical manufacturing company, FMC Corporation.
She has previously served as a global head of live biotherapeutics and nutraceuticals at Boehringer Ingelheim, where she led the creation of a new business unit, combining novel microbial based bio-therapeutic and diagnostic approaches.
She has also worked for Merial and Chr. Hansen.
Dr Flambard holds several vice president positions in the health and agriculture industries, as well as trustee positions and advisory roles for organizations in the consumer goods, pharmaceuticals and technology sectors. While growing core businesses, she has experience of seeding and developing growth opportunities into start-up businesses, focusing exclusively on the microbiome.
She has a Master of Administration from the University of Bath in the UK, a PhD in Molecular Genetics and Microbial Physiology from the National Institute of Agronomic in France, and a Master in Corporate Entrepreneurial Leadership from the Centre for Technology, Economics and Management in Denmark.
